Physician's Weekly2d
TNF Inhibitors vs Non-TNF DMARDs in Rheumatoid Arthritis-Associated Lung Disease
The following is a summary of “Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung ...
Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
BRIDGEWATER, NJ / ACCESS Newswire / March 24, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a ...
Healio1d
Addressing skin disease with medications alone is ‘not enough,’ diet also brings benefits
Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...
Rheumatology Advisor20h
TNF Inhibitor Use in RA With Early-Stage Cancer Does Not Decrease Survival
In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.
TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...
Healio6d
TNF inhibitors do not significantly impact survival in lung, prostate colorectal cancer
TNF inhibitor use demonstrates no negative impact on survival among patients recently diagnosed with colorectal, lung or ...
TNF Pharmaceuticals presents isomyosamine data
TNF Pharmaceuticals (TNFA) announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was ...
Fort Worth Star-Telegram2d
Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
In a murine model, a proprietary protease enzyme stabilized platform demonstrated successful delivery of infliximab, a tumor necrosis factor-alpha (TNF-α) inhibitor, in serum with concentrations ...